[1]
Sun, Y. et al. 2022. Role of Tepotinib, Capmatinib and Crizotinib in non-small cell lung cancer. Highlights in Science, Engineering and Technology. 6, (Jul. 2022), 321–327. DOI:https://doi.org/10.54097/hset.v6i.976.